Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.
Dillon HT, Saner NJ, Ilsley T, Kliman DS, Foulkes SJ, Brakenridge CJ, Spencer A, Avery S, Claus P, Dunstan DW, Daly RM, Fraser SF, Owen N, Lynch BM, Kingwell BA, La Gerche A, Howden EJ.
Dillon HT, et al. Among authors: howden ej.
Circulation. 2024 Nov 4. doi: 10.1161/CIRCULATIONAHA.124.070709. Online ahead of print.
Circulation. 2024.
PMID: 39492713